The Trump administration aims to issue a rule empowering regulators to “forcefully” go after companies that don’t share drug ...

Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, United States ...

--Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced new interim data from the randomized, double-blind, placebo-controlled Phase 1 clinical trial evaluating ...

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis Provided by GlobeNewswire May 8, 2025, 8:01:00 PM ...

Objectives Solid organ transplant recipients are at increased risk of skin cancer, affecting more than 50% of recipients. We aimed to determine the effectiveness of interventions for behavioural ...

The mean baseline EASI and IGA scores for soquelitinib patients were 20.4 and 3.0, respectively, compared to an EASI score of 18.5 and an IGA score of 3.3 for placebo patients.

Council Bluffs teacher arrested for controlled substances Council Bluffs Police said there is no indication that the school or any students are involved. Updated: 5:37 PM CST Nov 18, 2024 ...

The DEA extends COVID-era telemedicine prescribing flexibilities for controlled substances to December 31, 2025, allowing time for new rulemaking ...

Lo, Y. (2003) Relationships between the Hydrophilic-Lipophilic Balance Values of Pharmaceutical Excipients and Their Multidrug Resistance Modulating Effect in Caco-2 Cells and Rat Intestines. Journal ...

(2024-05-29 | NDAQ:MIRA) Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance. Stockhouse.com uses cookies on ...